Biotechnology investing is where Wall Street’s boldest risk-taking often lives. Clinical-stage biotech companies can deliver extraordinary returns—but only if everything goes right. Until pivotal trial data arrives, these stocks operate in a world of uncertainty, cash burn, and binary outcomes. ...